Cargando…
Current therapeutic options for coronavirus disease 2019 (COVID-19)—lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol
BACKGROUND: Coronavirus disease 2019 (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, first manifested in December 2019, and spread rapidly worldwide. Facing this lethal disease, there is an urgent need to develop potent therapies against SARS-CoV-2 i...
Autores principales: | Zhang, Zai-Li, Zhong, Han, Liu, Yang-Xi, Le, Ke-Jia, Cui, Min, Yu, Yue-Tian, Gu, Zhi-Chun, Gao, Yuan, Lin, Hou-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729372/ https://www.ncbi.nlm.nih.gov/pubmed/33313272 http://dx.doi.org/10.21037/atm-20-2340 |
Ejemplares similares
-
Middle East Respiratory Syndrome (MERS) Coronavirus
por: McFee, R.B.
Publicado: (2020) -
The search for therapeutic options for Middle East Respiratory Syndrome (MERS)
por: Arabi, Yaseen M., et al.
Publicado: (2016) -
Middle East respiratory syndrome (MERS) coronavirus and dromedaries
por: Wernery, Ulrich, et al.
Publicado: (2017) -
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS – MERS, MERS CoV
Publicado: (2017) -
The Middle East Respiratory Syndrome (MERS)
por: Azhar, Esam I., et al.
Publicado: (2019)